Change of geriatric morbidity and muscle mass of elderly patients with malignant disease after treatment with palliative and adjuvant chemotherapy

Completed

• Conditions: 10028302; cancer-induced muscle loss; chemotherapeutic induced muscle wasting; 10027655

• Registration Number: NL-OMON41437
• Lead Sponsor: Albert Schweitzer Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 450

Inclusion Criteria

1. Patients with malignant disease
2. 65 years of age and older
3. Patients undergoing chemotherapeutic treatment.

Exclusion Criteria

1. Previous systemic chemotherapeutic treatment during the last 3 months.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome:<br /><br>- Correlation sarcopenia and overall survival<br /><br><br /><br>Primary study parameter:<br /><br>- Sarcopenia (measured by slice-o-matic using CT-images)<br /><br>Primaire uitkomstmaat:</p><br>